{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:21:04Z","timestamp":1792131664332,"version":"4.4.0"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Doxorubicin (DOX) is still one of the leading compounds for cancer chemotherapy, but its clinical application has been restricted by the drug resistance. The emerging evidence has demonstrated that autophagy is a meticulously regulated by the lysosomal degradation as a regulator of this drug resistance. Autophagy can exert a pro-survival strategy under therapeutic stress through recycling cellular components, inhibiting apoptosis and remodelling metabolism, thereby enhancing carcinogenesis. The present review aims to highlight the interaction between autophagy and DOX resistance, providing the molecular machinery of autophagy and its control by genetic factors, microenvironmental factors and non-coding RNAs. Mechanistically, autophagy can be considered as protective or cytotoxic, relying on the cellular context, but in most cases, autophagy serves as a survival pathway promoting chemoresistance. The present review will also discuss about the function of DOX in autophagy induction through ROS generation, DNA damage response and AMPK\/mTOR axis, whereas providing context-specific adaptations including mitophagy in cancer stem cells and lysosomal remodelling. The pre-clinical studies have highlighted the function of pharmacological compounds and nanoparticles for the regulation of autophagy for improving DOX sensitivity in cancer, accelerating therapeutic index. The strategies have focused on the application of small-molecule inhibitors, natural compounds, nanocarrier-mediated co-delivery of DOX with autophagy modulators and the development of combination therapeites providing the crosstalk of autophagy and cell death mechanisms in DOX resistance. The clinical translation depends on the development of more effective autophagy-targeted drugs in combination therapies. Hence, the present review highlights the role of autophagy as a biomarker and therapeutic factors in reversing DOX resistance. By elucidating the complex biology linking autophagy to drug resistance, it is emphasized that tailored approaches integrating autophagy modulation may yield more effective and less toxic cancer treatments.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1642050","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:41:12Z","timestamp":1759232472000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation"],"prefix":"10.3389","volume":"16","author":[{"given":"Yantao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000168762","article-title":"Clinical nephrology in 19th century Germany","volume":"14","author":"Ritz","year":"1994","journal-title":"Am J Nephrol"},{"key":"B2","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26320","article-title":"A note from history: landmarks in history of cancer, part 3","volume":"118","author":"Hajdu","year":"2012","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035907","article-title":"A history of cancer research: tumor suppressor genes","volume":"12","author":"Lipsick","year":"2020","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.69","article-title":"Classifying the evolutionary and ecological features of neoplasms","volume":"17","author":"Maley","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fevo.2021.661583","article-title":"The hallmarks of cancer as ecologically driven phenotypes","volume":"9","author":"Somarelli","year":"2021","journal-title":"Front Ecol evolution"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-1158","article-title":"Convergent evolution, evolving evolvability, and the origins of lethal cancer","volume":"18","author":"Pienta","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resistance Updates"},{"key":"B12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00640-9","article-title":"Tumor microenvironment and radioresistance","volume":"53","author":"Suwa","year":"2021","journal-title":"Exp Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.200658","article-title":"Cancer and cure: A critical analysis","volume":"53","author":"Roy","year":"2016","journal-title":"Indian J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"J Am Med Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.872729","article-title":"Overcoming cancer drug resistance utilizing PROTAC technology","volume":"10","author":"Burke","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"B25","article-title":"The genetic origin of drug resistance in neoplasms: implications for systemic therapy","volume":"44","author":"Goldie","year":"1984","journal-title":"Cancer Res"},{"key":"B26","first-page":"1","article-title":"Experimental evaluation of potential anticancer agents. xiii. on the criteria and kinetics associated with \u201ccurability\u201d of experimental leukemia","volume":"35","author":"Skipper","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.15698\/mic2016.12.546","article-title":"Autophagy: machinery and regulation","volume":"3","author":"Yin","year":"2016","journal-title":"Microb Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2007.01050.x","article-title":"Hierarchy of Atg proteins in pre-autophagosomal structure organization","volume":"12","author":"Suzuki","year":"2007","journal-title":"Genes Cells"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.12.011","article-title":"Early steps in autophagy depend on direct phosphorylation of Atg9 by the Atg1 kinase","volume":"53","author":"Papinski","year":"2014","journal-title":"Mol Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.150.6.1507","article-title":"Tor-mediated induction of autophagy via an Apg1 protein kinase complex","volume":"150","author":"Kamada","year":"2000","journal-title":"J Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.8385367","article-title":"Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting","volume":"260","author":"Schu","year":"1993","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.152.3.519","article-title":"Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae","volume":"152","author":"Kihara","year":"2001","journal-title":"J Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.01.011","article-title":"Regulation of autophagy by phosphatidylinositol 3-phosphate","volume":"584","author":"Burman","year":"2010","journal-title":"FEBS Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803180200","article-title":"The Atg18-Atg2 complex is recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an essential function","volume":"283","author":"Obara","year":"2008","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.124.6.903","article-title":"Ultrastructural analysis of the autophagic process in yeast: detection of autophagosomes and their characterization","volume":"124","author":"Baba","year":"1994","journal-title":"J Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/35056522","article-title":"Molecular dissection of autophagy: two ubiquitin-like systems","volume":"2","author":"Ohsumi","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200801035","article-title":"In vivo reconstitution of autophagy in Saccharomyces cerevisiae","volume":"182","author":"Cao","year":"2008","journal-title":"J Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2016.49.8.081","article-title":"Role of the mammalian ATG8\/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy","volume":"49","author":"Lee","year":"2016","journal-title":"BMB Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/gb-2011-12-7-226","article-title":"Atg8: an autophagy-related ubiquitin-like protein family","volume":"12","author":"Shpilka","year":"2011","journal-title":"Genome Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.148.3.465","article-title":"Apg9p\/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways","volume":"148","author":"Noda","year":"2000","journal-title":"J Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201202061","article-title":"Atg9 vesicles are an important membrane source during early steps of autophagosome formation","volume":"198","author":"Yamamoto","year":"2012","journal-title":"J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4161\/auto.1.2.1840","article-title":"Atg9 cycles between mitochondria and the pre-autophagosomal structure in yeasts","volume":"1","author":"Reggiori","year":"2005","journal-title":"Autophagy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.151.2.263","article-title":"The reversible modification regulates the membrane-binding state of Apg8\/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway","volume":"151","author":"Kirisako","year":"2000","journal-title":"J Cell Biol"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.4161\/auto.19385","article-title":"A role for Atg8-PE deconjugation in autophagosome biogenesis","volume":"8","author":"Nair","year":"2012","journal-title":"Autophagy"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.20.5942-5955.2001","article-title":"Aut5\/Cvt17p, a putative lipase essential for disintegration of autophagic bodies inside the vacuole","volume":"183","author":"Epple","year":"2001","journal-title":"J Bacteriol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000739200","article-title":"Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase","volume":"276","author":"Teter","year":"2001","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e06-06-0479","article-title":"Atg22 recycles amino acids to link the degradative and recycling functions of autophagy","volume":"17","author":"Yang","year":"2006","journal-title":"Mol Biol Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12885-015-1239-4","article-title":"Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (\u2013)-Gossypol (AT-101)","volume":"15","author":"Mani","year":"2015","journal-title":"BMC Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2017.12.013","article-title":"Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3","volume":"416","author":"Hu","year":"2018","journal-title":"Cancer Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2045-3701-4-22","article-title":"Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy","volume":"4","author":"Han","year":"2014","journal-title":"Cell Bioscience"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110293","article-title":"Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer","volume":"9","author":"Ge","year":"2014","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.25","article-title":"Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells","volume":"38","author":"Fang","year":"2017","journal-title":"Acta Pharmacologica Sin"},{"key":"B53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41419-017-0242-x","article-title":"Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1239676","article-title":"GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1245263","article-title":"Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia","volume":"13","author":"Piya","year":"2017","journal-title":"Autophagy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.bbrc.2013.04.053","article-title":"Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells","volume":"434","author":"Wu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201621","article-title":"Autophagy mediates epithelial cancer chemoresistance by reducing p62\/SQSTM1 accumulation","volume":"13","author":"Battista","year":"2018","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.327","article-title":"Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells","volume":"8","author":"Pagotto","year":"2017","journal-title":"Cell Death Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4161\/auto.5.8.9996","article-title":"Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells","volume":"5","author":"Song","year":"2009","journal-title":"Autophagy"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219877931","article-title":"Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance","volume":"26","author":"Al-Malky","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(90)90155-C","article-title":"Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors","volume":"8","author":"Sinha","year":"1990","journal-title":"Free Radic Biol Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3727\/096504003108748294","article-title":"Differential ability of cytostatics from anthraquinone group to generate free radicals in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase","volume":"13","author":"Paw\u0142owska","year":"2003","journal-title":"Oncol Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0724rev","article-title":"The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage","volume":"18","author":"Fogli","year":"2004","journal-title":"FASEB J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10637-016-0388-x","article-title":"Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase II\u03b2 activity and cardiac function in a chronic rabbit model","volume":"34","author":"Frank","year":"2016","journal-title":"Invest New Drugs"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061809-100002","article-title":"New mechanistic and functional insights into DNA topoisomerases","volume":"82","author":"Chen","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.01.007","article-title":"DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis","volume":"332","author":"Roos","year":"2013","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.93.17.9166","article-title":"Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines","volume":"93","author":"Lotem","year":"1996","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B70","doi-asserted-by":"publisher","first-page":"120463","DOI":"10.1016\/j.lfs.2022.120463","article-title":"Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy","volume":"298","author":"Paskeh","year":"2022","journal-title":"Life Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/antiox10030349","article-title":"Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery","volume":"10","author":"Mirzaei","year":"2021","journal-title":"Antioxidants"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3390\/cancers11101528","article-title":"Inhibition of TFF3 enhances sensitivity\u2014and overcomes acquired resistance\u2014to doxorubicin in estrogen receptor-positive mammary carcinoma","volume":"11","author":"Poh","year":"2019","journal-title":"Cancers"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1123","article-title":"Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo","volume":"17","author":"Rajendran","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics12111084","article-title":"Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: enhancing antitumor activity","volume":"12","author":"Ashrafizadeh","year":"2020","journal-title":"Pharmaceutics"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.7150\/ijms.41980","article-title":"Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN","volume":"17","author":"Li","year":"2020","journal-title":"Int J Med Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"110268","DOI":"10.1016\/j.biopha.2020.110268","article-title":"LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p","volume":"129","author":"Wang","year":"2020","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001234","article-title":"Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma","volume":"134","author":"Xu","year":"2021","journal-title":"Chin Med J"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9163","article-title":"In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI\/ADR-RES cancer cells","volume":"8","author":"Morsy","year":"2020","journal-title":"PeerJ"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41419-020-03339-3","article-title":"Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures","volume":"12","author":"Raniolo","year":"2021","journal-title":"Cell Death Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8842","DOI":"10.3390\/ijms21228842","article-title":"Inhibition of AKT-signaling sensitizes soft tissue sarcomas (STS) and gastrointestinal stromal tumors (GIST) to doxorubicin via targeting of homology-mediated DNA repair","volume":"21","author":"Boichuk","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7150\/ijbs.52517","article-title":"miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy","volume":"17","author":"Chen","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2020.04.006","article-title":"Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics","volume-title":"Seminars in cancer biology","author":"Kirtonia","year":"2021"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.632206","article-title":"LINC01116 promotes doxorubicin resistance in osteosarcoma by epigenetically silencing miR-424-5p and inducing epithelial-mesenchymal transition","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5432651","DOI":"10.1155\/2020\/5432651","article-title":"Cellular mechanisms triggered by the cotreatment of resveratrol and doxorubicin in breast cancer: a translational in vitro\u2013in silico model","volume":"2020","author":"Vargas","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"B85","doi-asserted-by":"publisher","first-page":"116781","DOI":"10.1016\/j.carbpol.2020.116781","article-title":"Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA","volume":"250","author":"Yan","year":"2020","journal-title":"Carbohydr polymers"},{"key":"B86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/bioengineering7030091","article-title":"Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer","volume":"7","author":"Ashrafizadeh","year":"2020","journal-title":"Bioengineering"},{"key":"B87","doi-asserted-by":"publisher","first-page":"119430","DOI":"10.1016\/j.lfs.2021.119430","article-title":"Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy","volume":"277","author":"Mirzaei","year":"2021","journal-title":"Life Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"119368","DOI":"10.1016\/j.lfs.2021.119368","article-title":"Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems","volume":"275","author":"Mirzaei","year":"2021","journal-title":"Life Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"101119","DOI":"10.1016\/j.nantod.2021.101119","article-title":"Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy","volume":"38","author":"Delfi","year":"2021","journal-title":"Nano Today"},{"key":"B90","doi-asserted-by":"publisher","first-page":"10.1016","DOI":"10.1016\/j.carbpol.2021.117809","article-title":"Biomedical application of chitosan-based nanoscale delivery systems: potential usefulness in siRNA delivery for cancer therapy","volume":"260","author":"Ashrafizade","year":"2021","journal-title":"Carbohydr. Polym"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett"},{"key":"B92","doi-asserted-by":"publisher","first-page":"100671","DOI":"10.1016\/j.drup.2019.100671","article-title":"Towards the overcoming of anticancer drug resistance mediated by p53 mutations","volume":"49","author":"Cao","year":"2020","journal-title":"Drug Resistance Updates"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0767-4","article-title":"Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line","volume":"53","author":"Chan","year":"2004","journal-title":"Cancer chemotherapy Pharmacol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/fcp.12505","article-title":"NRF 2\/ABCB 1-mediated efflux and PARP 1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells","volume":"34","author":"Xia","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"12831","DOI":"10.18632\/oncotarget.14606","article-title":"A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03536-5","article-title":"The multifaceted role of reactive oxygen species in tumorigenesis","volume":"77","author":"Kirtonia","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"144807","DOI":"10.1016\/j.gene.2020.144807","article-title":"TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction","volume":"753","author":"Zhu","year":"2020","journal-title":"Gene"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3438-7","article-title":"The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer","volume":"36","author":"Xie","year":"2015","journal-title":"Tumor Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1158\/0008-5472.CAN-13-2620","article-title":"SIRT1 and AMPK mediate hypoxia-induced resistance of non\u2013small cell lung cancers to cisplatin and doxorubicin","volume":"74","author":"Shin","year":"2014","journal-title":"Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"13672","DOI":"10.1038\/s41598-018-31939-9","article-title":"Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells","volume":"8","author":"Taymaz-Nikerel","year":"2018","journal-title":"Sci Rep"},{"key":"B102","article-title":"Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma","volume":"8","author":"Bramwell","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B103","volume-title":"Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma","author":"Le Cesne","year":"1999"},{"key":"B104","article-title":"A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance","volume":"7","author":"Advani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/sj.bjc.6602653","article-title":"Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar","volume":"93","author":"Fracasso","year":"2005","journal-title":"Br J Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"106198","DOI":"10.1016\/j.leukres.2019.106198","article-title":"CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy","volume":"85","author":"Shang","year":"2019","journal-title":"Leukemia Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41419-019-2164-2","article-title":"miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4","volume":"10","author":"Du","year":"2019","journal-title":"Cell Death Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.7150\/thno.37628","article-title":"Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma","volume":"9","author":"Yan","year":"2019","journal-title":"Theranostics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.tranon.2021.101045","article-title":"Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348\/ATG7 axis","volume":"14","author":"Wang","year":"2021","journal-title":"Trans Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2017.03.018","article-title":"Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2","volume":"396","author":"Zhang","year":"2017","journal-title":"Cancer Lett"},{"key":"B111","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-019-2053-8","article-title":"miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2016.11.018","article-title":"Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells","volume":"388","author":"Yan","year":"2017","journal-title":"Cancer Lett"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.461","article-title":"Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy","volume":"34","author":"Gomes","year":"2015","journal-title":"Oncogene"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3704","article-title":"Simultaneous proteasome and autophagy inhibition synergistically enhances cytotoxicity of doxorubicin in breast cancer cells","volume":"40","author":"Loh","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"B115","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41420-024-01914-7","article-title":"miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition","volume":"10","author":"Naso","year":"2024","journal-title":"Cell Death Discov"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7476","article-title":"Suppression of DRP1\u2212mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy","volume":"43","author":"Ma","year":"2020","journal-title":"Oncol Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-012-1475-8","article-title":"Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes","volume":"350","author":"Dimitrakis","year":"2012","journal-title":"Cell Tissue Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbagen.2016.11.013","article-title":"Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line","volume":"1861","author":"Aydinlik","year":"2017","journal-title":"Biochim Biophys Acta (BBA) - Gen Subj"},{"key":"B120","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-016-2790-3","article-title":"Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Cancer"},{"key":"B121","article-title":"Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction","volume":"7","author":"Liu","year":"2017","journal-title":"Am J Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2055","article-title":"Autophagy prevents doxorubicin\u2212induced apoptosis in osteosarcoma","volume":"9","author":"Zhao","year":"2014","journal-title":"Mol Med Rep"},{"key":"B123","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/ijms18020370","article-title":"Inhibition of autophagy by deguelin sensitizes pancreatic cancer cells to doxorubicin","volume":"18","author":"Xu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.739145","article-title":"HMGB1 promotes resistance to doxorubicin in human hepatocellular carcinoma cells by inducing autophagy via the AMPK\/mTOR signaling pathway","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"108839","DOI":"10.1016\/j.cbi.2019.108839","article-title":"Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells","volume":"314","author":"Matsunaga","year":"2019","journal-title":"Chemico-Biological Interact"},{"key":"B126","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41420-024-02196-9","article-title":"Targeting oncogenic MAGEA6 sensitizes triple negative breast cancer to doxorubicin through its autophagy and ferroptosis by stabling AMPK\u03b11","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Death Discov"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1089\/aivt.2019.0007","article-title":"Contribution of autophagy in acquired drug resistance of human breast cancer cells MCF7 to doxorubicin","volume":"5","author":"Amani","year":"2019","journal-title":"Appl In Vitro Toxicol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.10.005","article-title":"Cholesterol-enriched membrane micro-domain deficiency induces doxorubicin resistance via promoting autophagy in breast cancer","volume":"23","author":"Shi","year":"2021","journal-title":"Mol Ther - Oncolytics"},{"key":"B129","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-024-03579-9","article-title":"Lysosomal gene ATP6AP1 promotes doxorubicin resistance via up-regulating autophagic flux in breast cancer","volume":"24","author":"Fei","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12712","article-title":"Src\/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy","volume":"106","author":"Tan","year":"2015","journal-title":"Cancer Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/ijo.2021.5229","article-title":"CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K\u2212Akt\u2212mTOR pathway inhibition","volume":"59","author":"Liao","year":"2021","journal-title":"Int J Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.565915","article-title":"Amino acid starvation sensitizes resistant breast cancer to doxorubicin-induced cell death","volume":"8","author":"Thomas","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037205","article-title":"Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2023.01.081","article-title":"Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines","volume":"648","author":"Natu","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13058-024-01951-1","article-title":"G-cleave LC3B biosensor: monitoring autophagy and assessing resveratrol\u2019s synergistic impact on doxorubicin-induced apoptosis in breast cancer cells","volume":"26","author":"Liao","year":"2024","journal-title":"Breast Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM10-5109","article-title":"Abstract 5109: Doxorubicin-induced autophagy functions as a pro-survival pathway in breast cancer cells","volume":"70","author":"Cosan","year":"2010","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04597-9","article-title":"Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1","volume":"478","author":"Hua","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1056970","article-title":"A novel autophagy\/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission","volume":"11","author":"Zhou","year":"2015","journal-title":"Autophagy"},{"key":"B139","doi-asserted-by":"publisher","first-page":"113856","DOI":"10.1016\/j.bcp.2020.113856","article-title":"Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin","volume":"175","author":"Zhong","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.594200","article-title":"Combination of metformin, sodium oxamate and doxorubicin induces apoptosis and autophagy in colorectal cancer cells via downregulation HIF-1\u03b1","volume":"11","author":"Coronel-Hern\u00e1ndez","year":"2021","journal-title":"Front Oncol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.10.034","article-title":"Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells","volume":"213","author":"Yang","year":"2018","journal-title":"Life Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/biom12111623","article-title":"Inhibition of autophagy promotes the elimination of liver cancer stem cells by CD133 aptamer-targeted delivery of doxorubicin","volume":"12","author":"Yin","year":"2022","journal-title":"Biomolecules"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3390\/cancers12092475","article-title":"Flavokawain B and doxorubicin work synergistically to impede the propagation of gastric cancer cells via ROS-mediated apoptosis and autophagy pathways","volume":"12","author":"Hseu","year":"2020","journal-title":"Cancers"},{"key":"B144","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/molecules24112102","article-title":"Paris polyphylla inhibits colorectal cancer cells via inducing autophagy and enhancing the efficacy of chemotherapeutic drug doxorubicin","volume":"24","author":"Lin","year":"2019","journal-title":"Molecules"},{"key":"B145","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12885-023-10774-w","article-title":"Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2018.10.019","article-title":"Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin","volume":"54","author":"Chen","year":"2019","journal-title":"Toxicol Vitro"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042265","article-title":"Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer","volume":"7","author":"Fong","year":"2012","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"109139","DOI":"10.1016\/j.biopha.2019.109139","article-title":"Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT\/mTOR and p38 signaling pathways","volume":"121","author":"Wei","year":"2020","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1434187","article-title":"Carvacrol nanoemulsion evokes cell cycle arrest, apoptosis induction and autophagy inhibition in doxorubicin resistant-A549 cell line","volume":"46","author":"Khan","year":"2018","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jphp.12322","article-title":"Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis","volume":"67","author":"Friedhuber","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2022-0171","article-title":"Hyperthermia and doxorubicin release by fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells","volume":"17","author":"Kulkarni-Dwivedi","year":"2022","journal-title":"Nanomedicine"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2016.1185731","article-title":"Sensitization of multidrug-resistant Malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition","volume":"27","author":"Gao","year":"2017","journal-title":"J Liposome Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"140455","DOI":"10.1016\/j.cej.2022.140455","article-title":"Biodegradable doxorubicin-loaded ferric phosphate nanosheets for specific tumor elimination through autophagy inhibition-enhanced apoptosis\/ferroptosis pathway","volume":"454","author":"Yang","year":"2023","journal-title":"Chem Eng J"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1176232","article-title":"Co-delivery of doxorubicin and hydroxychloroquine via chitosan\/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.7150\/thno.70852","article-title":"Drug-induced self-assembled nanovesicles for doxorubicin resistance reversal via autophagy inhibition and delivery synchronism","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00879","article-title":"Codelivery of doxorubicin and shAkt1 by poly(ethylenimine)\u2013glycyrrhetinic acid nanoparticles to induce autophagy-mediated liver cancer combination therapy","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Pharmaceutics"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/ijms25021164","article-title":"Enhanced sensitivity of A549 cells to doxorubicin with WS2 and WSe2 nanosheets via the induction of autophagy","volume":"25","author":"Jin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.11.009","article-title":"MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1","volume":"10","author":"Liang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B159","article-title":"Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma","volume":"7","author":"Bao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2060","article-title":"Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer","volume":"20","author":"Chittaranjan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-018-0689-3","article-title":"SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition","volume":"37","author":"Wang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"113443","DOI":"10.1016\/j.biopha.2022.113443","article-title":"Diterpene promptly executes a non-canonical autophagic cell death in doxorubicin-resistant lung cancer","volume":"153","author":"Chiu","year":"2022","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B163","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1038\/s41598-017-03230-w","article-title":"TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKK\u03b2\/AMPK\u03b1\/mTOR pathway","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.09.035","article-title":"Isoginkgetin synergizes with doxorubicin for robust co-delivery to induce autophagic cell death in hepatocellular carcinoma","volume":"153","author":"Wang","year":"2022","journal-title":"Acta Biomaterialia"},{"key":"B165","doi-asserted-by":"publisher","first-page":"108105","DOI":"10.1016\/j.lungcan.2025.108105","article-title":"ENDOLUNG trial, part II. A phase II study of the Akt\/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel\/carboplatin in patients with squamous non-small cell lung cancer","volume":"201","author":"Bosch-Barrera","year":"2025","journal-title":"Lung Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040984","article-title":"Differential involvement of autophagy and apoptosis in response to chemoendocrine and endocrine therapy in breast cancer: JBCRG-07TR","volume":"20","author":"Ueno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-4042","article-title":"A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine\/nab-paclitaxel in pancreatic cancer patients","volume":"26","author":"Zeh","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejca.2017.02.020","article-title":"Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials","volume":"77","author":"Berger","year":"2017","journal-title":"Eur J Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.4161\/auto.29231","article-title":"Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors","volume":"10","author":"Mahalingam","year":"2014","journal-title":"Autophagy"},{"key":"B170","doi-asserted-by":"publisher","first-page":"100559","DOI":"10.1016\/j.medj.2024.11.012","article-title":"Targeting autophagy plus high-dose CDK4\/6 inhibitors in advanced HR+HER2- breast cancer: A phase 1b\/2 trial","volume":"6","author":"Gong","year":"2025","journal-title":"Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.4161\/auto.29119","article-title":"Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma","volume":"10","author":"Rangwala","year":"2014","journal-title":"Autophagy"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0621","article-title":"Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): phase II trial of high dose pantoprazole (Autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer (mCRPC)","volume":"24","author":"Hansen","year":"2019","journal-title":"Oncologist"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02356-1","article-title":"A Phase 1\/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma","volume":"129","author":"Lopez","year":"2023","journal-title":"Br J Cancer"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0086","article-title":"Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma","volume":"19","author":"Wolpin","year":"2014","journal-title":"Oncologist"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3HI0715-305R","article-title":"High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy","volume":"100","author":"Parker","year":"2016","journal-title":"J Leukocyte Biol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad020","article-title":"SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt\/mTOR pathway","volume":"113","author":"Zhang","year":"2023","journal-title":"J Leukocyte Biol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-023-02714-0","article-title":"Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells","volume":"42","author":"Wei","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.023","article-title":"Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma","volume":"62","author":"Li","year":"2015","journal-title":"J Hepatol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1815439","article-title":"Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3\/VPS34","volume":"16","author":"Janji","year":"2020","journal-title":"Autophagy"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1703921114","article-title":"Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner","volume":"114","author":"Mgrditchian","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1038\/s41467-023-41618-7","article-title":"Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer","volume":"14","author":"Taraborrelli","year":"2023","journal-title":"Nat Commun"},{"key":"B182","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13046-024-03023-w","article-title":"Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer","volume":"43","author":"Zhang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B183","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.3390\/cells11244127","article-title":"C-MYC inhibited ferroptosis and promoted immune evasion in ovarian cancer cells through NCOA4 mediated ferritin autophagy","volume":"11","author":"Jin","year":"2022","journal-title":"Cells"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2037119","article-title":"Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer","volume":"18","author":"Zhan","year":"2022","journal-title":"Autophagy"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.04.031","article-title":"Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy","volume":"357","author":"Yang","year":"2023","journal-title":"J Controlled Release"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2300280","DOI":"10.1002\/smll.202300280","article-title":"Nanodrug inducing autophagy inhibition and mitochondria dysfunction for potentiating tumor photo-immunotherapy","volume":"19","author":"Xiao","year":"2023","journal-title":"Small"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.05.034","article-title":"Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy","volume":"335","author":"Xia","year":"2021","journal-title":"J Controlled Release"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b00143","article-title":"In situ manipulation of dendritic cells by an autophagy-regulative nanoactivator enables effective cancer immunotherapy","volume":"13","author":"Wang","year":"2019","journal-title":"ACS Nano"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c00227","article-title":"A redox-triggered autophagy-induced nanoplatform with PD-L1 inhibition for enhancing combined chemo-immunotherapy","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2002160","DOI":"10.1002\/adma.202002160","article-title":"On-demand autophagy cascade amplification nanoparticles precisely enhanced oxaliplatin-induced cancer immunotherapy","volume":"32","author":"Wang","year":"2020","journal-title":"Advanced Materials"},{"key":"B191","doi-asserted-by":"publisher","first-page":"2207898","DOI":"10.1002\/smll.202207898","article-title":"Tailor-made autophagy cascade amplification polymeric nanoparticles for enhanced tumor immunotherapy","volume":"19","author":"Long","year":"2023","journal-title":"Small"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c02183","article-title":"Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking tumor cell autophagy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"B193","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.nantod.2023.101936","article-title":"A minimalist dendrimer nanodrug for autophagy inhibition-amplified tumor photothermo-immunotherapy","volume":"51","author":"Ouyang","year":"2023","journal-title":"Nano Today"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.02.008","article-title":"Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c00041","article-title":"Conjugation of macrophage-mimetic microalgae and liposome for antitumor sonodynamic immunotherapy via hypoxia alleviation and autophagy inhibition","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1642050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:41:29Z","timestamp":1759232489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1642050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":195,"alternative-id":["10.3389\/fimmu.2025.1642050"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1642050","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"article-number":"1642050"}}